- CO2 extracted
- Non GMO
- No pesticides
- Non psychoactive
- Rapid bioavailability
- Regulates the human Endocannabinoid system
- Sourced from USA grown industrial hemp.
- This tincture is made 100% from the whole hemp plant.
Full spectrum hemp extract, hemp seed oil, MCT oil, vanilla extract, Stevia vanilla extract. Add to your daily health routine to promote mind and body wellness. It has been enhanced for maximum shelf life and maximum bio-absorption giving our customers a full spectrum cannabinoid proﬁle. None of our ingredients have been chemically synthesized in a lab.
This product should be used sublingually, i.e. under the tongue.
Suggested serving size: 1/2 dropper, take by mouth two times daily.
These statements have not been evaluated by the FDA.
This product is not intended to diagnose, treat, cure or prevent any disease.
- Servings Per Container30
- Serving Size45 drops (1ml)
- Amount per serving
- % Daily Value*
- Total Fat1 g1.28%
- Saturated Fat1 g5%
- Cholesterol0 mg0%
- Sodium0 mg0%
- Total Carbohydrate0 g0%
- Total Sugars0 g
- Protein0 g0%
CERTIFICATE OF ANALYSIS
Click here to view.
|1 FL OZ Bottle||1 Dropperful (1 ML)|
|CBD Concentration||mg of CBD per bottle||mg of CBD per Dropperful|
|Low||100 / 250||3.3 / 8.3 mg|
|Medium||500 / 600 / 800||16.7 / 20.0 / 26.7 mg|
|High||1000 / 1500||33.3 / 50.0 mg|
The Endocannabinoid System (ECS) is a built in biological receptor system in human beings. Over time animals and humans have developed cooperative relationships with other animals and plants in the living ecosystem. The human body generates compounds called endocannabinoids, while hemp produces phytocannabinoids. The ECS’s overall function is to regulate homeostasis, to keep balance, stabilization, and well being in the human body. Homeostatis is a key element in the biology of all living things and is best explained as the ability to maintain stable internal conditions necessary for survival. Endocannabiniods and their receptors in the human body are located within the brain, organs, connective tissues and immune cells. The ECS activates an impacts a variety of physiological process including appetite, pain-sensation, nausea, mood and memory.
Terpenes and phytocannabiniods originate in the same glands of the cannabis plant (Hemp). When ingested, the terpenes act as an assistant to cannabinoids as they work to penetrate the blood-brain barrier.
Phytocannabinoids also known as cannabinoids, are diverse natural compounds derived from hemp extract. These phytocannabinoids exert their affects interacting with specific cannabinoid receptors present on the surface cells within the human body. In other words, Phytocannabinoids activate the endocannabinoid system.
CBD is an entirely different compound from THC, and its effects are very complex. It is not psychoactive, meaning it does not produce a “high” or change a person’s state of mind, but it influences the body to use its own endocannabinoids more effectively.
According to one study posted to Neurotherapeutics, this is because CBD itself does very little to the ECS. Instead, it activates or inhibits other compounds in the endocannabinoid system.
For example, CBD stops the body from absorbing anandamide, a compound associated with regulating pain. So, increased levels of anandamide in the bloodstream may reduce the amount of pain a person feels.
Hemp extract consists of a blend of natural occuring compounds known as phytocannabinoids and terpenes.
In the United States, CBD oil has varying legality across different states and at a federal level, yet it currently has a range of applications and promising possibilities.
Multiple sclerosis (MS) is an autoimmune disease that affects the entire body through the nerves and brain.
Muscle spasms are one of the most common symptoms of MS. These spasms can be so great they cause constant pain in some people.
One report found that short-term use of CBD oil could reduce the levels of spasticity a person feels. The results are modest, but many people reported a reduction in symptoms. More studies on humans are needed to verify these results.
The same report studied CBD use for general chronic pain. Researchers compiled the results of multiple systematic reviews covering dozens of trials and studies. Their research concluded that there is substantial evidence that cannabis is an effective treatment for chronic pain in adults.
A separate study in the Journal of Experimental Medicine supports these results. This research suggests that using CBD can reduce pain and inflammation.
The researchers also found that subjects were not likely to build up a tolerance to the effects of CBD, so they would not need to increase their dose continually.
They noted that cannabinoids, such as CBD, could offer helpful new treatments for people with chronic pain.
A study in the European Journal of Pain used an animal model to see if CBD could help people with arthritis manage their pain. Researchers applied a topical gel containing CBD to rats with arthritis for 4 days.
Their researchers note a significant drop in inflammation and signs of pain, without additional side effects.